Ori Biotech
Ori Biotech develops automated manufacturing platforms for cell and gene therapies, enabling pharmaceutical companies to scale production from research to commercial levels. The company has raised $139M, including a Series B round in January 2022.
The growth story
Ori Biotech grew from 32 to 72 employees between 2021 and 2026, raising $139M along the way, most recently a Series B in January 2022.
About
Ori Biotech sells manufacturing systems that automate and standardize the production of personalized cell and gene therapies. Its closed-platform technology helps pharmaceutical companies overcome the complexity of scaling these treatments from lab research to mass production.
The company has grown to 72 employees since its 2015 founding. Its $139M in funding comes from notable life science investors including Northpond Ventures and Novalis LifeSciences, with its Series B round closing in early 2022.
Founders and leadership
Engineering is Ori Biotech's largest function, with 13 employees. The company operates from dual headquarters in London and Philadelphia, reflecting its transatlantic focus in the pharmaceutical manufacturing industry.
The Ori Biotech org chart
Jason C. Foster (Chief Executive Officer and Executive Director) leads 30 mapped leaders with 3 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Engineering 17 (-47% YoY), Business Development 15 (-17% YoY), Operations 8 (-20% YoY), Entrepreneurship 7 (-12% YoY), Program and Project Management 4 (0% YoY), Quality Assurance 4 (+33% YoY).
Talent flow
Ori Biotech recruits heavily from UCL, which accounts for 8 of its 53 analyzed profiles. Its workforce also includes alumni from Thermo Fisher Scientific, Cambridge Design Partnership, and several pharmaceutical companies. Alumni have gone on to roles at Morgan Stanley, Deloitte, and life science startups.
Most common previous employers of Ori Biotech staff: UCL (7), Thermo Fisher Scientific (4), Cambridge Design Partnership (4), Indivior (3), Reckitt (3), Minaris (3). Former Ori Biotech employees most often moved to Cellular Origins (2), Fresenius Kabi (2), CCA Bio (2), Morgan Stanley (2), Geodesic Labs (2), Deloitte (2).
Alumni worth knowing
The Ori Biotech mafia
Six Ori Biotech alumni have founded companies, including Alchemi (21 staff), Halloway (6 staff), and CCA Bio (4 staff). These startups span diagnostics, biotech, and healthcare technology.
6Tom Mulvey, was Chief of Staff until 2022Mike Avena, was Head of Information Technology until 2024Kieran Clarke, was Go To Market and Product Management Consultant until 2025Lizzie Melhuish, was Mechanical Engineering Consultant until 2025John Machulski, was Chief Operating Officer until 2025Web traffic
Traffic mix: 68% direct, 17% search, 7% social, 0% paid.
What this company is made of
Most common skills at Ori Biotech: Microsoft Office (23), Product Development (21), Research Skills (21), Biotechnology (20), Leadership (19), Microsoft Excel (19), Project Management (19), Microsoft Word (19).
Where the team actually sits
Ori Biotech people are concentrated in England, United Kingdom (26), Greater Cambridge Area (4), United Kingdom (3), New Jersey, United States (3). 3 offices on record.
Search footprint
Ori Biotech attracts about 149 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 41 ranking keywords and lost 23 in the last period.
What employees say
- Compensation
- 3.90 / 5
- Career opportunities
- 3.90 / 5
- Senior management
- 4.40 / 5
- Work-life balance
- 3.90 / 5
Frequently asked
Ori Biotech has 72 employees as of September 2026.
Ori Biotech has raised $139M in total, most recently a Series B round in January 2022.
Ori Biotech was founded in 2015 by Farlan Singh Veraitch.
Jason C. Foster (Chief Executive Officer and Executive Director) sits at the top of Ori Biotech's reporting structure, with 3 direct reports.
The most common previous employers of current Ori Biotech staff are UCL (7 people), Thermo Fisher Scientific (4 people), Cambridge Design Partnership (4 people).
Former Ori Biotech employees most often move to Cellular Origins (2), Fresenius Kabi (2), CCA Bio (2).
At least 6 companies have a founder who previously worked at Ori Biotech, including Alchemi, Halloway, CCA Bio.
Ori Biotech attracts about 149 organic search visits a month, worth roughly $1K a month in equivalent ad spend.
The most common skills among Ori Biotech staff are Microsoft Office, Product Development, Research Skills, Biotechnology, Leadership.
Ori Biotech staff are concentrated in England, United Kingdom (26), Greater Cambridge Area (4), United Kingdom (3).
Ori Biotech has about 17 people in Engineering, down 47% over the past year, as of September 2026.
Ori Biotech has about 15 people in Business Development, down 17% over the past year, as of September 2026.
Computed from 53 current and 111 former Ori Biotech profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.